A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1994
12/08/1994	WO1994027623A1 Anti-cholesterolemic egg, vaccine and method for production, and use
12/08/1994	WO1994027613A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	WO1994027585A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	WO1994027584A2 Arylating medicaments
12/08/1994	WO1994027581A1 Methods and apparatus for making liposomes
12/08/1994	WO1994027435A1 Genetic immunization with cationic lipids
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024163A3 Bispecific antigen-binding molecules
12/08/1994	WO1994021807A3 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
12/08/1994	WO1994021273A3 USE OF ANGIOGENINE, AND/OR α1-MICROGLOBULINE AND/OR COMPLEMENTARY FACTOR D FOR LIMITING PROTEIN SECRETION
12/08/1994	WO1994016096A3 Method to predict active growth of bacteria adhered to a surface
12/08/1994	WO1994004675A3 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family
12/08/1994	DE4403057C1 Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them
12/08/1994	DE4318307A1 The use of lectins for the therapy of acute and chronic pancreatitis in humans
12/08/1994	CA2163903A1 Methods and apparatus for making liposomes using critical, supercritical or near critical fluids
12/08/1994	CA2163741A1 Peptide inhibitors of urokinase receptor activity
12/08/1994	CA2163737A1 Anti-cholesterolemic egg, vaccine and method for production and use
12/08/1994	CA2163652A1 Compositions and methods for treating cancer and hyperproliferative disorders
12/08/1994	CA2163638A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	CA2163459A1 Arylating medicaments
12/08/1994	CA2163438A1 Regulator of contact-mediated hemolysin
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163264A1 Bandage for continuous application of biologicals
12/08/1994	CA2163227A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	CA2163226A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	CA2163225A1 Lhrh antagonists
12/08/1994	CA2163013A1 Human calcium sensor
12/08/1994	CA2162855A1 Expression of urokinase plasminogen activator inhibitors
12/08/1994	CA2162726A1 Modified factor vii
12/08/1994	CA2162610A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock
12/08/1994	CA2162271A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein
12/08/1994	CA2161979A1 Cloning, expression and uses of dorsalin-1
12/08/1994	CA2161015A1 Transgenic mammals lacking expression of particular cd45 isoforms
12/08/1994	CA2141540A1 Monoclonal antibody, method for preparing the same and use of the same
12/08/1994	CA2123555A1 Intraocular irrigating solution
12/07/1994	EP0627489A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated
12/07/1994	EP0627487A2 Ligands for FLT3 receptors
12/07/1994	EP0627486A1 New extracellular superoxide dismutase, a process for preparing the same and compositions containing the same
12/07/1994	EP0627444A1 Monoacetic derivatives of the peptides leu-phe-ala and ala-leu-phe and their use in identifying and destroying tumour cells, viruses and virus-carrying cells
12/07/1994	EP0627223A1 Topical composition with therapeutic and cosmetic activity, containing aloe vera and modified natural collagen
12/07/1994	EP0627219A1 Use of calmodulin inhibitors for neuroprotection
12/07/1994	EP0627003A1 Stem cell inhibiting proteins
12/07/1994	EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4
12/07/1994	EP0627001A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
12/07/1994	EP0627000A1 Mammalian expression systems for hcv proteins
12/07/1994	EP0626973A1 Phenylalanine analogs of bombesin
12/07/1994	EP0626860A1 Enzyme castration of animals and tumor treatment
12/07/1994	EP0626859A1 Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
12/07/1994	EP0626858A1 Antiviral agent
12/07/1994	EP0626857A1 Improved peritoneal dialysis solutions with polypeptides
12/07/1994	EP0626847A1 Histamine derivatives and methods for their use as immunomodulators
12/07/1994	EP0469079B1 Non-absorbable cholesterol esterase inhibitors for decreasing cholesterol absorption
12/07/1994	EP0416035B1 Amphiphilic peptides and use thereof
12/07/1994	EP0322438B1 Purified follicle stimulating hormone
12/07/1994	EP0210189B1 Recombinant alveolar surfactant protein
12/07/1994	CN1026862C Process for producting of dry bioactive recombinant growth hormones
12/06/1994	US5371206 DNA encoding chimeric fibroblast growth factors
12/06/1994	US5371204 Interleukins
12/06/1994	US5371196 Process for producing secretory immunoglobulin A preparations
12/06/1994	US5371193 Useful in pharmaceutical preparations for stimulating and/or enchancing cells involved in the immune response and those involved in proper functioning of the hematopoietic system
12/06/1994	US5371191 Osteoinductive protein mixtures and purification processes
12/06/1994	US5371189 Monocyte-derived insulin receptor regulatory factor
12/06/1994	US5371186 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
12/06/1994	US5371185 Theraputical agent
12/06/1994	US5371085 Method for treating fish diseases
12/06/1994	US5371081 N-substituted phenoxazines for treating multidrug resistant cancer cells
12/06/1994	US5371073 Polypeptide factors from colostrum
12/06/1994	US5371072 Asp-Pro-Arg α-keto-amide enzyme inhibitors
12/06/1994	US5371071 Peptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascade
12/06/1994	US5371070 Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins
12/06/1994	US5371017 Hepatitis C virus protease
12/06/1994	US5371007 Precipitation; controlling proteolytic enzyme activity
12/06/1994	US5370995 L-phenylalanyl-tRNA synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins
12/06/1994	US5370991 Cloned gene encoding human monocyte elastase inhibitor
12/06/1994	US5370870 Administering growth hormone. tumor necrosis factor, D-factor or mixture; treating tissues, organs to be transplanted
12/06/1994	US5370869 Infusion into patient platelet concentrate that has been in contact with povidone-iodine or povidone-hydrogen peroxide or mixture to inactivate or destroy pathogenic microorganism
12/06/1994	US5370815 Peroxidase, peroxide, iodide compound, and surfactants and buffers; enzyme generated free iodide radical
12/06/1994	CA1333442C Wavelength-specific cytotoxic agents
12/06/1994	CA1333363C Angiogenesis inhibitor comprising fumagillin
12/05/1994	CA2125080A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
12/04/1994	CA2125021A1 Alpha-heteroaryloxymethyl ketones as interleukin-1 beta converting enzyme inhibitors
12/04/1994	CA2124989A1 Endothelin antagonistic peptide
12/01/1994	DE4323754C1 New bifunctional urokinase derivs and related plasmids
11/1994
11/30/1994	EP0626447A1 Monoclonal antibodies and Fv specific for cd2 antigen
11/30/1994	EP0626390A1 Humanised antibodies
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626376A1 Octacyclodepsipeptides having endoparasiticidal activity
11/30/1994	EP0626375A1 Octacyclodepsipeptides having endoparasiticidal activity
11/30/1994	EP0626178A1 Use of inhibitors of HIV-protease for the treatment of tumorous diseases
11/30/1994	EP0626177A2 Nutrition for persons infected with human immunodeficiency virus
11/30/1994	EP0626176A2 Nutrition for persons undergoing radiation therapy and/or chemotherapy
11/30/1994	EP0626175A2 Enteral nutritional product
11/30/1994	EP0626174A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
11/30/1994	EP0626170A2 Stabilisation of pharmacologically active compounds in sustained release compositions
11/30/1994	EP0626169A2 A dosage form comprising an antigen and a salt form of an organic acid derivative of a sterol
11/30/1994	EP0625991A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625989A1 Dna sequences encoding novel growth/differentiation factors
11/30/1994	EP0625988A1 Allosteric modulators of the nmda receptor
11/30/1994	EP0625987A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace

1 ... 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 ... 3163